Newsletter Signup x
More children with cancer are able to ring the end of treatment bell, thanks to our funding. Read our new #ImpactReport here: https://t.co/PAlIaJ3SG4 #30YearsofImpact #ChildhoodCancer pic.twitter.com/VvTFwmkCmF
— Children with Cancer UK (@CwC_UK) August 29, 2019
Our research has helped make treatment more effective for children with cancer. Learn about the MRD test and how we’ve helped to develop it here: https://t.co/PAlIaJ3SG4 #30YearsofImpact #ChildhoodCancer pic.twitter.com/FPSQgsM5aQ
— Children with Cancer UK (@CwC_UK) August 22, 2019
We’re providing better clinical facilities and funding research into new treatments for children with cancer. Find out more about our impact here: https://t.co/PAlIaJ3SG4 #30YearsofImpact #ChildhoodCancer #KeepingFamiliesTogether pic.twitter.com/qvGqoSpi6O
— Children with Cancer UK (@CwC_UK) August 15, 2019
Curious to know what we've achieved since our founding, 30 years ago? We're delighted to share our new #ImpactReport, based on an independent review by @TheKingsFund. Find out more here: https://t.co/PAlIaJ3SG4 #30YearsofImpact pic.twitter.com/yzj7ISRyLS
— Children with Cancer UK (@CwC_UK) August 8, 2019
Characterising and targeting treatment resistant cells in Acute Lymphoblastic Leukaemia following treatment
Acute lymphoblastic leukaemia (ALL) is the most common childhood cancer. Most children and young adults with ALL are treated
Read more